Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1975 1
1976 2
1977 2
1978 3
1979 5
1980 8
1982 1
1983 6
1984 2
1986 2
1987 8
1988 24
1989 38
1990 12
1991 18
1992 18
1993 32
1994 23
1995 22
1996 20
1997 25
1998 25
1999 29
2000 36
2001 33
2002 42
2003 27
2004 38
2005 56
2006 53
2007 62
2008 45
2009 43
2010 53
2011 49
2012 67
2013 73
2014 60
2015 65
2016 78
2017 77
2018 109
2019 90
2020 90
2021 93
2022 78
2023 67

Text availability

Article attribute

Article type

Publication date

Search Results

1,656 results

Results by year

Filters applied: . Clear all
Page 1
Duchenne muscular dystrophy.
Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duan D, et al. Nat Rev Dis Primers. 2021 Feb 18;7(1):13. doi: 10.1038/s41572-021-00248-3. Nat Rev Dis Primers. 2021. PMID: 33602943 Free PMC article. Review.
Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads to difficulties with movement and, eventually, to the need for assisted ventilation and premature death. ...Recent studies have greatly deepened our understanding of the p …
Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads to difficulties with movement a …
Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.
Sun C, Shen L, Zhang Z, Xie X. Sun C, et al. Genes (Basel). 2020 Jul 23;11(8):837. doi: 10.3390/genes11080837. Genes (Basel). 2020. PMID: 32717791 Free PMC article. Review.
Neuromuscular disorders encompass a heterogeneous group of conditions that impair the function of muscles, motor neurons, peripheral nerves, and neuromuscular junctions. Being the most common and most severe type of muscular dystrophy, Duchenne muscular …
Neuromuscular disorders encompass a heterogeneous group of conditions that impair the function of muscles, motor neurons, peripheral nerves, …
Gene Therapy for Duchenne Muscular Dystrophy.
Elangkovan N, Dickson G. Elangkovan N, et al. J Neuromuscul Dis. 2021;8(s2):S303-S316. doi: 10.3233/JND-210678. J Neuromuscul Dis. 2021. PMID: 34511510 Free PMC article. Review.
Duchenne muscular dystrophy (DMD) is an X-linked, muscle wasting disease that affects 1 in 5000 males. ...
Duchenne muscular dystrophy (DMD) is an X-linked, muscle wasting disease that affects 1 in 5000 males. ...
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.
Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM; DMD Care Considerations Working Group. Birnkrant DJ, et al. Lancet Neurol. 2018 Apr;17(4):347-361. doi: 10.1016/S1474-4422(18)30025-5. Epub 2018 Feb 3. Lancet Neurol. 2018. PMID: 29395990 Free PMC article. Review.
A coordinated, multidisciplinary approach to care is essential for optimum management of the primary manifestations and secondary complications of Duchenne muscular dystrophy (DMD). Contemporary care has been shaped by the availability of more sensitive diagn …
A coordinated, multidisciplinary approach to care is essential for optimum management of the primary manifestations and secondary complicati …
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.
Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR; DMD Care Considerations Working Group. Birnkrant DJ, et al. Lancet Neurol. 2018 Mar;17(3):251-267. doi: 10.1016/S1474-4422(18)30024-3. Epub 2018 Feb 3. Lancet Neurol. 2018. PMID: 29395989 Free PMC article. Review.
Since the publication of the Duchenne muscular dystrophy (DMD) care considerations in 2010, multidisciplinary care of this severe, progressive neuromuscular disease has evolved. ...
Since the publication of the Duchenne muscular dystrophy (DMD) care considerations in 2010, multidisciplinary care of t …
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.
Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifirò G. Crisafulli S, et al. Orphanet J Rare Dis. 2020 Jun 5;15(1):141. doi: 10.1186/s13023-020-01430-8. Orphanet J Rare Dis. 2020. PMID: 32503598 Free PMC article. Review.
BACKGROUND: Duchenne Muscular Dystrophy (DMD) is a rare disorder caused by mutations in the dystrophin gene. ...
BACKGROUND: Duchenne Muscular Dystrophy (DMD) is a rare disorder caused by mutations in the dystrophin gene. ...
Duchenne Muscular Dystrophy: From Diagnosis to Therapy.
Falzarano MS, Scotton C, Passarelli C, Ferlini A. Falzarano MS, et al. Molecules. 2015 Oct 7;20(10):18168-84. doi: 10.3390/molecules201018168. Molecules. 2015. PMID: 26457695 Free PMC article. Review.
Duchenne muscular dystrophy (DMD) is an X-linked inherited neuromuscular disorder due to mutations in the dystrophin gene. ...
Duchenne muscular dystrophy (DMD) is an X-linked inherited neuromuscular disorder due to mutations in the dystrophin ge …
Duchenne muscular dystrophy.
Yiu EM, Kornberg AJ. Yiu EM, et al. J Paediatr Child Health. 2015 Aug;51(8):759-64. doi: 10.1111/jpc.12868. Epub 2015 Mar 9. J Paediatr Child Health. 2015. PMID: 25752877 Review.
Duchenne muscular dystrophy, an X-linked disorder, has an incidence of one in 5000 boys and presents in early childhood with proximal muscle weakness. ...The use of corticosteroids, non-invasive respiratory support, and active surveillance and management of a …
Duchenne muscular dystrophy, an X-linked disorder, has an incidence of one in 5000 boys and presents in early childhood …
The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review.
Ryder S, Leadley RM, Armstrong N, Westwood M, de Kock S, Butt T, Jain M, Kleijnen J. Ryder S, et al. Orphanet J Rare Dis. 2017 Apr 26;12(1):79. doi: 10.1186/s13023-017-0631-3. Orphanet J Rare Dis. 2017. PMID: 28446219 Free PMC article. Review.
BACKGROUND: Duchenne Muscular Dystrophy (DMD) is a rapidly progressive, lethal neuromuscular disorder, present from birth, which occurs almost exclusively in males. ...
BACKGROUND: Duchenne Muscular Dystrophy (DMD) is a rapidly progressive, lethal neuromuscular disorder, present from bir …
Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy.
Nascimento Osorio A, Medina Cantillo J, Camacho Salas A, Madruga Garrido M, Vilchez Padilla JJ. Nascimento Osorio A, et al. Neurologia (Engl Ed). 2019 Sep;34(7):469-481. doi: 10.1016/j.nrl.2018.01.001. Epub 2018 Mar 9. Neurologia (Engl Ed). 2019. PMID: 29526319 Free article. English, Spanish.
INTRODUCTION: Duchenne muscular dystrophy (DMD) is the most common myopathy in children, with a worldwide prevalence of approximately 0.5 cases per 10,000 male births. It is characterised by a progressive muscular weakness manifesting in early childhoo …
INTRODUCTION: Duchenne muscular dystrophy (DMD) is the most common myopathy in children, with a worldwide prevalence of …
1,656 results